Download App

Log in to access Online Inquiry
Company Overview More
Yasheng Pharmaceutical Group is an investment holding company mainly engaged in the development of innovative microtreatments for cancer, hepatitis B virus and a number of aging-related diseases. The company has a self-developed protein-protein interaction targeting drug design platform. The company's main products include the next generation kinase inhibitor HQP1351, apoptosis targeting drugs APG-1252, APG2575, APG-115 and so on. The company operates in the domestic market and overseas markets such as the United States.
CEO: Dajun Yang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > 06855 ASCENTAGE-B > Detailed Quotes

06855 ASCENTAGE-B

14.080-0.620-4.22%
Market Close 05/25 16:08 CCT
High
14.700
Open
14.700
Turnover
16.13M
Low
14.000
Pre Close
14.700
Volume
1.13M
Market Cap
3.70B
P/E(TTM)
Loss
52wk High
58.200
Shares
262.95M
P/E(Static)
Loss
52wk Low
11.160
Float Cap
3.70B
Bid/Ask %
36.13%
Historical High
58.200
Shs Float
262.95M
Volume Ratio
0.37
Historical Low
11.160
Dividend TTM
--
Div Yield TTM
--
P/B
2.45
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.43%
Amplitude
4.76%
Avg Price
14.303
Lot Size
100
Float Cap
3.70B
Bid/Ask %
36.13%
Historical High
58.200
Shs Float
262.95M
Volume Ratio
0.37
Historical Low
11.160
Dividend TTM
--
P/B
2.45
Dividend LFY
--
Turnover Ratio
0.43%
Amplitude
4.76%
Avg Price
14.303
Lot Size
100
Price Forecast

No Data

News

Comment